Short and Long Term Measures of Anxiety Exhibit Opposite Results

Animal models of human diseases of the central nervous system, generalized anxiety disorder included, are essential for the study of the brain-behavior interface and obligatory for drug development; yet, these models fail to yield new insights and efficacious drugs. By increasing testing duration hundredfold and arena size tenfold, and comparing the behavior of the common animal model to that of wild mice, we raise concerns that chronic anxiety might have been measured at the wrong time, for the wrong duration, and in the wrong animal. Furthermore, the mice start the experimental session with a short period of transient adaptation to the novel environment (habituation period) and a long period reflecting the respective trait of the mice. Using common measures of anxiety reveals that mice exhibit opposite results during these periods suggesting that chronic anxiety should be measured during the post-habituation period. We recommend tools for measuring the transient period, and provide suggestions for characterizing the post habituation period.

[1]  C. S. Hall,et al.  Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality. , 1934 .

[2]  C. S. Hall,et al.  Emotional behavior in the rat. III. The relationship between emotionality and ambulatory activity. , 1936 .

[3]  W. I. Welker,et al.  “Free” versus “Forced” Exploration of a Novel Situation by Rats , 1957 .

[4]  F. Goodwin,et al.  Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines , 1980, Pharmacology Biochemistry and Behavior.

[5]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[6]  Pharmacology and anxiety: Inadequacies of current experimental approaches and working models , 1988, Pharmacology Biochemistry and Behavior.

[7]  R. Lister Ethologically-based animal models of anxiety disorders. , 1990, Pharmacology & therapeutics.

[8]  Simon Benhamou,et al.  An analysis of movements of the wood mouse Apodemus sylvaticus in its home range , 1991, Behavioural Processes.

[9]  S. Hogg A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety , 1996, Pharmacology Biochemistry and Behavior.

[10]  C. Belzung,et al.  Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety , 1997, Behavioural pharmacology.

[11]  R. Rodgers Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.

[12]  Y. Clément,et al.  Biological bases of anxiety , 1998, Neuroscience & Biobehavioral Reviews.

[13]  D. Treit,et al.  Effects of centrally administered anxiolytic compounds in animal models of anxiety , 1999, Neuroscience & Biobehavioral Reviews.

[14]  M. Low,et al.  Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli , 1999, The Journal of Neuroscience.

[15]  R. Andreatini,et al.  Animal models: Trait or state measure? The test-retest reliability of the elevated plus-maze and behavioral despair , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[16]  Yoav Benjamini,et al.  Rats and mice share common ethologically relevant parameters of exploratory behavior , 2001, Behavioural Brain Research.

[17]  G. Griebel,et al.  Measuring normal and pathological anxiety-like behaviour in mice: a review , 2001, Behavioural Brain Research.

[18]  C. Belzung,et al.  Environmental enrichment in BALB/c mice Effects in classical tests of anxiety and exposure to a predatory odor , 2001, Physiology & Behavior.

[19]  S. Gosling From mice to men: what can we learn about personality from animal research? , 2001, Psychological bulletin.

[20]  J. Crabbe,et al.  A rating scale for wildness and ease of handling laboratory mice: results for 21 inbred strains tested in two laboratories , 2003, Genes, brain, and behavior.

[21]  Takeshi Sakurai,et al.  Hypothalamic Orexin Neurons Regulate Arousal According to Energy Balance in Mice , 2003, Neuron.

[22]  Frauke Ohl,et al.  Testing for anxiety , 2003, Clinical Neuroscience Research.

[23]  C. Belzung,et al.  The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. , 2003, European journal of pharmacology.

[24]  E. Nestler,et al.  Neurobehavioral assessment in the information age , 2004, Nature Neuroscience.

[25]  Victoria J. Bakker,et al.  Gap‐Crossing Decisions by the Red Squirrel, a Forest‐Dependent Small Mammal , 2004 .

[26]  I. Kola,et al.  Can the pharmaceutical industry reduce attrition rates? , 2004, Nature Reviews Drug Discovery.

[27]  F. Sams-Dodd Target-based drug discovery: is something wrong? , 2005, Drug discovery today.

[28]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[29]  A. P. Carobrez,et al.  Ethological and temporal analyses of anxiety-like behavior: The elevated plus-maze model 20 years on , 2005, Neuroscience & Biobehavioral Reviews.

[30]  L. de Visser,et al.  Novel approach to the behavioural characterization of inbred mice: automated home cage observations , 2006, Genes, brain, and behavior.

[31]  Y. Benjamini,et al.  Wild mouse open field behavior is embedded within the multidimensional data space spanned by laboratory inbred strains , 2006, Genes, brain, and behavior.

[32]  I. Whishaw,et al.  The point of entry contributes to the organization of exploratory behavior of rats on an open field: An example of spontaneous episodic memory , 2007, Behavioural Brain Research.

[33]  D. Murphy,et al.  What's wrong with my mouse model? Advances and strategies in animal modeling of anxiety and depression , 2007, Behavioural Brain Research.

[34]  J. Caston,et al.  Free versus forced exposure to an elevated plus-maze: evidence for new behavioral interpretations during test and retest , 2009, Psychopharmacology.

[35]  A. Ennaceur,et al.  Are benzodiazepines really anxiolytic? Evidence from a 3D maze spatial navigation task , 2008, Behavioural Brain Research.

[36]  M. Stein,et al.  Developing Novel Anxiolytics: Improving Preclinical Detection and Clinical Assessment , 2008 .

[37]  D. Collier,et al.  Interspecies Trait Genetics Reveals Association of Adcy8 with Mouse Avoidance Behavior and a Human Mood Disorder , 2009, Biological Psychiatry.

[38]  Thomas Steckler,et al.  Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models , 2009, Neuropsychopharmacology.

[39]  L. Tecott,et al.  Chronic Citalopram Administration Causes a Sustained Suppression of Serotonin Synthesis in the Mouse Forebrain , 2009, PloS one.

[40]  Yoav Benjamini,et al.  Freedom of movement and the stability of its unfolding in free exploration of mice , 2009, Proceedings of the National Academy of Sciences.

[41]  S. Hyman,et al.  Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.

[42]  Y. Benjamini,et al.  Quantifying the buildup in extent and complexity of free exploration in mice , 2011, Proceedings of the National Academy of Sciences.

[43]  J. Cryan,et al.  The age of anxiety: role of animal models of anxiolytic action in drug discovery , 2011, British journal of pharmacology.

[44]  Toshihiko Shiroishi,et al.  A new twist on behavioral genetics by incorporating wild-derived mouse strains. , 2011, Experimental animals.

[45]  J. Haller,et al.  Current animal models of anxiety, anxiety disorders, and anxiolytic drugs , 2012, Current opinion in psychiatry.

[46]  B. Spruijt,et al.  High‐throughput phenotyping of avoidance learning in mice discriminates different genotypes and identifies a novel gene , 2012, Genes, brain, and behavior.

[47]  I. Golani,et al.  Validation of the dimensionality emergence assay for the measurement of innate anxiety in laboratory mice , 2012, European Neuropsychopharmacology.